Subscribe
Does Aduhelm mark the return of science-based medicine?

The Podcast by KevinMD

Does Aduhelm mark the return of science-based medicine?

"While we still lack a complete cause and effect model of Alzheimer’s disease, there is no doubt that the etiology is multifaceted and nonlinear. This accounts for the fact that…
August 19, 2021

Does Aduhelm mark the return of science-based medicine?

“While we still lack a complete cause and effect model of Alzheimer’s disease, there is no doubt that the etiology is multifaceted and nonlinear. This accounts for the fact that it takes an incredibly long time for Alzheimer’s disease to develop. I mention this because one of the major problems with FDA approval has always been that it insists on utilizing the same framework and methodology of approving drugs designed to treat long-term diseases as it would with short-term diseases.”

Robert Trent is a graduate student who blogs at Medaphysics.

He shares his story and discusses his KevinMD article, “Does the FDA approval of aducanumab mark the return of science-based medicine?” (https://www.kevinmd.com/blog/2021/07/does-the-fda-approval-of-aducanumab-mark-the-return-of-science-based-medicine.html)

You may also like

The Best Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Y’all Means All Communities are powered by people—and the variety of lives, jobs, schedules, and skills keep cities buzzing. Providing care means healthcare has to show up for "y’all" no matter the gender identity, work schedule, or preferred language.